An FDA inspection claims that eye-tracking biomarker developer RightEye misbranded and adulterated its medical device. The agency wrote in a letter, dated Dec. 20, 2022, that it inspected RightEye’s Bethesda, Maryland facility over 10 days in June and July 2022. In this inspection, it declared the RightEye Vision System a Class II Nystagmograph medical device. […]
righteye
RightEye raises $7.3 million from VSP Global, angel investors
Eyecare company VSP Global said today that it has made an investment in RightEye and its game-based vision tests. VSP (Rancho Cordova, Calif.) did not disclose the amount it provided RightEye (Bethesda, Md.) in the Series A round. But an SEC Form D that RightEye filed in June shows a roughly $7.3 million money-raise, which a spokesperson for VSP confirmed included […]